Share this post on:

Product Name :
GLS-012

Search keywords :
Relatlimab

drugId :
null

Target Vo:
Lymphocyte activation gene 3 protein

Target Vo Short Name :
LAG3

Moa_Name:
Lymphocyte activation gene 3 protein inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Harbin Gloria Pharmaceuticals Co Ltd

Active Company_Name :
Guangzhou Gloria Biosciences Co Ltd

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
GPX1 Antibody
HDAC1 Antibody
Met (C-Met) Antibody: Met (C-Met) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 156 kDa, targeting to Met (C-Met). It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human.

Share this post on:

Author: Interleukin Related